Guselkumab (Anti-IL-23)

Guselkumab (Anti-IL-23) is a recombinant human IgG1 monoclonal antibody. It targets the key IL-23 and inhibits the production of cytokines lying downstream of the IL-23 signaling pathway and can be used for reatment of psoriatic arthritis, Crohn's disease, and ulcerative colitis. MW : 145.5 KD.
Supplier Selleck Chemicals
Product # A2438
Sku # A2438-1mg
Pricing 1mg, $770.00
Feedback